Prodrugs of 2,4 pyrimidinediamine compounds and their uses
US7563892B1 · kind B1 · utility
41Cited by
36References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2006 |
| Grant date | Jul 21, 2009 |
| Priority date | — |
| Expiry date | Mar 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65742
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides the 2,4-pyrimidinediamine compound shown below, compositions comprising the compound, intermediates and methods for synthesizing the compound, and methods of using the compound in a variety of applications including treatment of autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.